Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, April 18, 2018
[ Wed, Apr 18th 2018
] - WOPRAI
[ Wed, Apr 18th 2018
] - WOPRAI
[ Wed, Apr 18th 2018
] - WOPRAI
[ Wed, Apr 18th 2018
] - WOPRAI
[ Wed, Apr 18th 2018
] - WOPRAI
Tue, April 17, 2018
[ Tue, Apr 17th 2018
] - WOPRAI
[ Tue, Apr 17th 2018
] - WOPRAI
[ Tue, Apr 17th 2018
] - WOPRAI
[ Tue, Apr 17th 2018
] - WOPRAI
[ Tue, Apr 17th 2018
] - WOPRAI
[ Tue, Apr 17th 2018
] - WOPRAI
[ Tue, Apr 17th 2018
] - WOPRAI
[ Tue, Apr 17th 2018
] - WOPRAI
[ Tue, Apr 17th 2018
] - WOPRAI
[ Tue, Apr 17th 2018
] - WOPRAI
[ Tue, Apr 17th 2018
] - WOPRAI
[ Tue, Apr 17th 2018
] - WOPRAI
[ Tue, Apr 17th 2018
] - WOPRAI
[ Tue, Apr 17th 2018
] - WOPRAI
[ Tue, Apr 17th 2018
] - WOPRAI
[ Tue, Apr 17th 2018
] - WOPRAI
[ Tue, Apr 17th 2018
] - WOPRAI
[ Tue, Apr 17th 2018
] - WOPRAI
Mon, April 16, 2018
[ Mon, Apr 16th 2018
] - WOPRAI
Steven Valiquette Maintained (CAH) at Hold with Decreased Target to $68 on, Apr 16th, 2018
Steven Valiquette of Barclays, Maintained "Cardinal Health, Inc." (CAH) at Hold with Decreased Target from $74 to $68 on, Apr 16th, 2018.
Steven has made no other calls on CAH in the last 4 months.
There are 2 other peers that have a rating on CAH. Out of the 2 peers that are also analyzing CAH, 1 agrees with Steven's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Ross Muken of "Evercore ISI Group" Initiated at Hold and Held Target at $67 on, Friday, January 5th, 2018
This is the rating of the analyst that currently disagrees with Steven
- David Toung of "Argus Research" Upgraded from Hold to Strong Buy and Held Target at $85 on, Monday, April 2nd, 2018
